| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.088 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |